Related Experiment Videos
Human platelet-immune complex interaction in plasma
The Journal of Laboratory and Clinical Medicine
|December 1, 1982
Summary
In systemic lupus erythematosus (SLE), insoluble DNA-anti-DNA immune complexes activate human platelets, causing aggregation and release. This process involves the platelet Fc-receptor and is key to understanding SLE pathogenesis.
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of anti-DNA antibodies.
- Immune complexes (ICs) play a central role in SLE pathogenesis, but their direct effects on platelet function are not fully understood.
Purpose of the Study:
- To investigate the impact of DNA-anti-DNA immune complexes on human platelet aggregation and release.
- To elucidate the mechanism by which immune complexes interact with platelets, specifically involving the Fc-receptor.
Main Methods:
- Analysis of anti-DNA antibody populations in SLE patient plasma.
- Formation and characterization of precipitating (insoluble) and soluble DNA-anti-DNA immune complexes.
- Incubation of human platelets with immune complexes and assessment of aggregation and release.
- Investigation of Fc-receptor involvement using Fc-fragments and blocking agents.
Main Results:
- Insoluble DNA-anti-DNA immune complexes induced significant platelet aggregation and release.
- Platelet activation correlated positively with insoluble IC formation, not soluble ICs.
- Soluble ICs and Fc-fragments inhibited the release reaction, suggesting competition for Fc-receptors.
- Blocking Fc-pieces of insoluble ICs inhibited release, confirming Fc-receptor mediation.
Conclusions:
- Insoluble DNA-anti-DNA immune complexes activate human platelets via the platelet Fc-receptor.
- This interaction leads to platelet aggregation and release, contributing to SLE pathophysiology.
- Antibody conformational changes upon antigen binding may enhance Fc-receptor interaction.